Skip to main content
SpringerLink
Log in

Steroid Hormones and the Aging Skeleton

  • Chapter
Hormone und Psyche die Endokrinologie des Alternden Menschen

Part of the book series: Symposion der Deutschen Gesellschaft für Endokrinologie ((ENDOKRINOLOGIE,volume 5))

Abstract

Modern medical advances in many fields are responsible for reduced rates of death and disabling disease and for improved conditions of health, each of which increases life expectancy at all ages (1). One of the most important problems is the rapidly expanding group of aging people. It has been predicted that by 1980, approximately 40 per cent of the population of the United States (that is, 120 million people) will be over the age of 45 years (2). The corresponding number for Europe would be more than 240 million!

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Nelson, W. O.: Endocrinology — Achievement and Challenge. Endocrinology 59, 140–152 (1956).

    Article  PubMed  CAS  Google Scholar 

  2. Stieglitz, E. J.: Medicine Today and Tomorrow. Read at Medical Research Conference on the Clinical Problems of Advancing Years, Smith, Kline, and French Laboratories. Philadelphia March 16, 1949.

    Google Scholar 

  3. Reifenstein, E. C., jr., and F. Albright: The Metabolic Effects of Steroid Hormones in Osteoporosis. J. clin. Invest. 26, 24–56 (1947).

    Article  CAS  Google Scholar 

  4. Reifenstein, E. C., jr., and F. Albright: Metabolic Disorders of Bone. In Principles of Internal Medicine, T. R. Harrison, Editor. 2nd Edition, Chapter 49, pp. 404–418, and Chapters 97–105, pp. 697–730. New York: Blakiston Co. 1954; and 3rd Edition, 1958 (in press).

    Google Scholar 

  5. Reifenstein, E. C., jr., and F. Albright: The Definitions, Terminology, and Classification of Metabolic Bone Disorders. In Clinical Orthopedics, A. F. Depalma, Editor. Number 9, pp. 30–45. Philadelphia: J. B. Lippincott Co. 1957.

    Google Scholar 

  6. Reifenstein, E. C., jr., and F. Albright: Diseases of the Parathyroid Glands. In Textbook of Endocrinology, R. H. Williams, Editor. 2nd Edition, pp. 483–581, and 717–727, Philadelphia: W. B. Saunders Co., 1955.

    Google Scholar 

  7. Reifenstein, E. C., jr., and R. P. Howard: The Parathyroid Glands. In Glandular Physiology and Therapy Published under the auspices of the Council on Pharmacy and Chemistry, American Medical Association. Chapter 51, pp. 351–385, Philadelphia: J. B. Lippincott Co. 1954.

    Google Scholar 

  8. Albright, F., and E. C. Reifenstein jr.: The Parathyroid Glands and Metabolic Bone Disease: Selected Studies. Baltimore: Williams & Wilkins Co. 1948.

    Google Scholar 

  9. Albright, F., and E. C. Reifenstein Jr. E. Bloomberg and P. H. Smith: Postmenopausal Osteoporosis. Trans. Assoc. Amer. Phycns 55, 298–305 (1940).

    CAS  Google Scholar 

  10. Albright, F., and E. C. Reifenstein Jr. P.H. Smith and A.M. Richardson: Postmenopausal Osteoporosis: Its Clinical Features. J. Amer. med. Assoc. 116, 2465–2474 (1941).

    Article  Google Scholar 

  11. Albright, F., and E. C. Reifenstein Jr. C. H. Burnett, O. Cope and W. Parson: Acute Atrophy of Bone (Osteoporosis) Simulating Hyperparathyroidism. J. clin. Endoer. 1, 711–716 (1941).

    Article  CAS  Google Scholar 

  12. Albright, F., and E. C. Reifenstein Jr. C. H. Burnett, O. Cope and W. Parson: Cushing’s Syndrome: Its Pathological Physiology, Its Relationship to the Adrenogenital Syndrome, and Its Connection with the Problem of the Reaction of the Body to Injurious Agents (“Alarm Reaction” of Selye). Harvey Lect. Ser. 38, 123–186 (1942- 1943).

    Google Scholar 

  13. Albright, F., and E. C. Reifenstein Jr. C. H. Burnett, O. Cope and W. Parson: Osteoporosis. Ann. intern. Med. 27, 861–882 (1947).

    PubMed  CAS  Google Scholar 

  14. Albright, F., and E. C. Reifenstein Jr. C. H. Burnett, O. Cope and W. Parson: The Effect of Hormones on Osteogenesis in Man. Recent Progr. Hormone Res.: Proc. Laurentian Hormone Conf. 1, 293–353 (1947).

    CAS  Google Scholar 

  15. Kinsell, L. W.: Consideration of Calcium and Phosphorus Metabolism, Including the Normal and Pathologic Physiology of the Parathyroid Glands. Amer. Practit. 3, 499–505 (1949).

    CAS  Google Scholar 

  16. Howard, R. P.: Medical Aspects of Bone Disease with Particular Reference to Osteoporosis. Canad. med. Assoc. J. 63, 258–264 (1950).

    PubMed  CAS  Google Scholar 

  17. Gordan, G. S.: Metabolic Bone Diseases in Practice: Osteoporosis, Paget’s Disease, von Recklinghausen’s Disease, and Albright’s Syndrome. Amer. Practit. 2, 113–1951).

    Google Scholar 

  18. Gordan, G. S.: Evaluation and Use of Anabolic Steroids. GP 10, 87–102 (1954).

    PubMed  CAS  Google Scholar 

  19. Bauer, W., and F. C. Bartter: Diseases of the Bones. In Textbook of Medicine, R. L. Cecil and R. F. Loeb, Editors. 9th Edition, pp. 1445–1475. Philadelphia: W. B. Saunders Co., 1954.

    Google Scholar 

  20. Moldawer, M.: Senile Osteoporosis: The Physiological Basis of Treatment. A. M. A. Arch, intern. Med. 96, 202–214 (1955).

    Article  CAS  Google Scholar 

  21. Moldawer, M.: Pathogenesis and Treatment of Senile Osteoporosis. Geriatrics 11, 319–331 (1956).

    PubMed  CAS  Google Scholar 

  22. Kolb, F. O.: Metabolic Bone Diseases in the Adult. Kaiser Fdn. med. Bull. 4, 348–360 (1956).

    Google Scholar 

  23. Laszlo, D., and H. Spencer: Newer Techniques in the Study of Calcium Metabolism in Man and Effects of Hormones Thereon. In Hormones and the Aging Process, E. T. Engle and G. Pincus, Editors, pp. 175–200, Academic Press, Inc., 1956.

    Google Scholar 

  24. Tutt, M., B. Kidman, B. Raynor and J. Vaughan: The Deposition of Sr 89 in Rabbit Bones Following Intravenous Injection. Brit. J. exp. Path. 33, 207–215 (1952).

    PubMed  CAS  Google Scholar 

  25. Babaiantz, L.: The Osteoporoses. Radiol, clin. 16, 291–322 (1947).

    CAS  Google Scholar 

  26. Fusi, G.: Experimental Studies on the First Radiological Manifestation of Osteoporosis. Radiol, clin. 22, 123–129 (1953).

    CAS  Google Scholar 

  27. Lachman, E., and M. Whelan: Roentgen Diagnosis of Osteoporosis and Its Limitations. Radiology 26, 165–177 (1936).

    Google Scholar 

  28. Lachman, E., and M. Whelan: Osteoporosis: The Potentialities and Limitations of Its Roentgenologic Diagnosis. Amer. J. Roentgenol. 74, 712–715 (1955).

    Google Scholar 

  29. Shohl, A. T.: Mineral Metabolism, p. 19. New York: Reinhold Publ. Corp. 1939.

    Google Scholar 

  30. Whedon, G. D.: Steroid Hormones in Osteoporosis. In Hormones and the Aging Process, E. T. Engle and G. Pincus, Editors, pp. 221–239. New York: Academic Press, Inc. 1956.

    Google Scholar 

  31. Perloff, W. H., J. H. Boutwell, jr. and R. Maas: The Endocrine Treatment of Climacteric (Steroid-Deficiency) Osteoporosis. J. Amer. Geriat. Soc. 4, 760–765 (1956).

    PubMed  Google Scholar 

  32. Cooke, A.M.: Osteoporosis. Lancet 1955, 877–882; 929–937.

    Google Scholar 

  33. Reifenstein, E. C., jr.: The Rationale for the Use of Anabolic Steroids in Controlling the Adverse Effects of Corticoid Hormones Upon Protein and Osseous Tissues. South, med. J. (Bgham, Ala.) 49, 933–960 (1956).

    Article  CAS  Google Scholar 

  34. Talbot, N. B., E. H. Sobel, J. W. Mcarthur and J. D. Crawford: Functional Endocrinology: From Birth Through Adolescence. Cambridge, Mass.: Harvard University Press 1952.

    Google Scholar 

  35. Wilkins, L.: A Feminizing Adrenal Tumor Causing Gynecomastia in a Boy of Five Years Contrasted with a Virilizing Tumor in a Five-Year-Old Girl: Classification of Seventy Cases of Adrenal Tumor in Children According to Their Hormonal Manifestations and a Review of Eleven Cases of Feminizing Adrenal Tumor in Adults. J. clin. Endocr. 8, 111–132 (1948).

    Article  PubMed  CAS  Google Scholar 

  36. Fräser, R. W., A. P. Forbes, F. Albright, H. W. Sulkowitch and E. C. Reifenstein, jr.: Colorimetric Assay of 17-Ketosteroids in Urine. A Survey of the Use of This Test in Endocrine Investigation, Diagnosis, and Therapy. J. clin. Endocr. 1, 234–256 (1941).

    Article  Google Scholar 

  37. Hamilton, H. B., and J. B. Hamilton: Ageing in Apparently Normal Men. I. Urinary Titers of Ketosteroids and of Alpha-Hydroxy and Beta-Hydroxy Ketosteroids. J. clin. Endocr. 8, 433–452 (1948).

    Article  PubMed  CAS  Google Scholar 

  38. Hamburger, C.: Normal Urinary Excretion of Neutral 17-Ketosteroids with Special Reference to Age and Sex Variations. Acta endocr. (Kbh.) 1,19–37 (1948).

    CAS  Google Scholar 

  39. Pincus, G., L. P. Romanoff and J. Carlo: The Excretion of Urinary Steroids by Men and Women of Various Ages. J. Geront. 9, 113–132 (1954).

    PubMed  CAS  Google Scholar 

  40. Pincus, G., L. P. Romanoff, R. I. Dorfman, L. P. Romanoff, B. L. Rubin, E. Bloch, J. Carlo and H. Freeman: Steroid Metabolism in Aging Men and Women. Recent Progr. Hormone Res.: Proc. 1954 Laurentian Hormone Conf. 11, 307–341 (1955).

    Google Scholar 

  41. Pincus, G., L. P. Romanoff, R. I. Dorfman, L. P. Romanoff, B. L. Rubin, E. Bloch, J. Carlo and H. Freeman: Aging and Urinary Steroid Excretion. In Hormones and the Aging Process, E. T. Engle and G. Pincus, Editors, pp. 1–20. New York: Academic Press, Inc. 1956.

    Google Scholar 

  42. Black, J. R., R. K. Ghormley and J. D. Camp: Senile Osteoporosis of the Spinal Column. J. Amer. med. Assoc. 117, 2144–2150 (1941).

    Article  Google Scholar 

  43. Gershon-Cohen, J., A. M. Rechtman; and H. Schraer: Asymptomatic Fractures in Osteoporotic Spines of the Aged. J. Amer. med. Assoc. 153, 625–627 (1953).

    Article  CAS  Google Scholar 

  44. Reifeinstein, E. C., jr., F. Albright and S.L. Wells: The Accumulation, Interpretation, and Presentation of Data Pertaining to Metabolic Balances, Notably Those of Calcium, Phosphorus, and Nitrogen. J. clin. Endocr. 5, 367–395 (1945).

    Article  Google Scholar 

  45. Shorr, E.: Effect of Strontium on the Calcium Balance of Patients with Osteoporosis. Trans. Macy Conference on Metabolic Aspects of Convalescence, Including Bone and Wound Healing 6, 124–129 (1944).

    Google Scholar 

  46. Shorr, E., and A. C. Carter: Studies on the Effect of Estrogens, Androgens, and Vitamin D2 on the Calcium and the Strontium Metabolism. Trans. Macy Conference on Metabolic Aspects of Convalescence, Including Bone and Wound Healing 15, 99–113 (1947).

    Google Scholar 

  47. Shorr, E., and A. C. Carter: Strontium as an Adjuvant in the Treatment of Post-Menopausal Osteoporosis. Trans. Macy Conference on Metabolic Aspects of Convalescence, Including Bone and Wound Healing 16, 122–146 (1947).

    Google Scholar 

  48. Shorr, E., and A. C. Carter:: The Value of Strontium as an Adjuvant to Calcium in the Remineralization of the Skeleton in Osteoporosis in Man. Trans. Macy Conference on Metabolic Interrelations, with Special Reference to Calcium. 2, 144–154 (1950).

    Google Scholar 

  49. Shorr, E., and A. C. Carter: The Usefulness of Strontium as an Adjuvant to Calcium in the Remineralization of the Skeleton in Man. Bull. Hosp. Jt. Dis. 13, 59–66 (1952).

    CAS  Google Scholar 

  50. Michon, P., Lochard and Gaussin: Implantation of Estradiol (Estrogen) in Postmenopausal Osteoporosis; Report of a Case. Rev med. Nancy 73, 143–147 (1948).

    PubMed  CAS  Google Scholar 

  51. Sherman, M. S.: Estrogens and Bone Formation in the Human Female. J. Bone Jt. Surg. 30A, 915–930 (1948).

    CAS  Google Scholar 

  52. Anderson, I. A.: Postmenopausal Osteoporosis; Clinical Manifestations and the Treatment with Oestrogens. Quart. J. Med. 19, 67–96 (1950).

    Google Scholar 

  53. Hart, G. M.: Postmenopausal Osteoporosis of the Spine. Geriatrics 5, 321–330 (1950).

    PubMed  CAS  Google Scholar 

  54. Greisheimer, E. M.: Postmenopausal Osteoporosis. J. Amer. med. Women’s Assoc. 6, 183–184 (1951).

    CAS  Google Scholar 

  55. Labhart, A. and A. Schupbach: Treatment of Osteoporosis with Sex Hormones. Schweiz, med. Wschr. 1951, 992–995.

    Google Scholar 

  56. Snapper, I.: Osteoporosis. Med. clin. N. Amer. 1952, 847.

    Google Scholar 

  57. Schoene, R. H.: A Clinical Attempt at Treating Senile Osteoporosis. Ohio State med. J. 48, 126 (1952).

    CAS  Google Scholar 

  58. Bartelheimer, H.: The Clinical Significance, the Diagnosis, and the Treatment of Osteoporosis. Ärztl. Wschr. 1953, 1137.

    Google Scholar 

  59. Bartelheimer, H., J. M. Schmitt-Rohde: The Pathogenesis of Osteoporosis. Ergebn. inn. Med. Kinder- heilk. N. F. 7, 454–585 (1956).

    CAS  Google Scholar 

  60. Banghart, H. E.: A Clinical Evaluation of Methyl Androstenediol in the Treatment of Osteoporosis. Amer. Practit. 5, 964–966 (1954).

    Article  CAS  Google Scholar 

  61. Bogdonoff, M. D., N. W. Shock and J. Parsons: The Effects of Stilbestrol on the Retention of Nitrogen, Calcium, Phosphorus, and Potassium in Aged Males With and Without Osteoporosis. J. Geront. 9, 262–275 (1954).

    PubMed  CAS  Google Scholar 

  62. Lichtwitz, A., and D. Clement: Hormone Regulation and Tissue Metabolism. Sem. Hop. Paris 9, 2911 (1954).

    Google Scholar 

  63. Lichtwitz, A., R. Parlier, D. Clement and M. Delaville: The Metabolism of Calcium and Steroids. Sem. Hop. Paris 10, 554 (1955).

    Google Scholar 

  64. Mackenzie, D. A., and J. M. Janes: Postmenopausal Osteoporosis: A Programme of Treatment in 42 Cases. Canad. med. Assoc. J. 71, 339–340 (1954).

    PubMed  CAS  Google Scholar 

  65. Pearson, S., J. Weissberg and T. H. Mcgavack: Steroid Studies. I. Metabolic Effects of Androstanolone in Aged People. J. Amer. Geriat. Soc. 2, 26–31 (1954).

    PubMed  CAS  Google Scholar 

  66. Spencer, H., A. Hausinger and D. Laszlo: The Calcium Tolerance Test in Senile Osteoporosis. J. Amer. Geriat. Soc. 2, 19–25 (1954).

    PubMed  CAS  Google Scholar 

  67. Wolf, J. and A. A. Loeser: Testosterone Therapy for Fractures and Certain Malignant and Nonmalignant Bone Conditions. J. clin. Endocr. 14,107–109 (1954).

    Article  Google Scholar 

  68. Watkins, D. M., J. M. Parsons, M. J. Yiengst and N. W. Shock: Metabolism in the Aged: The Effect of Stanolone on the Retention of Nitrogen, Potassium, Phosphorus, and Calcium and on the Urinary Excretion of 17-Keto, 11-Oxy, and 17-Hydroxy Steroids in Eight Elderly Men on High and Low Protein Diets. J. Geront. 10, 268–287 (1955).

    Google Scholar 

  69. Gordan, G. S.: Anabolic Therapy. Proceedings of a Conference on The Clinical Use of Anabolic Agents. Searle Res. Lab., Chicago (April 9) 1956.

    Google Scholar 

  70. Weinberg, M.: Osteoporosis: Diagnosis and Treatment. J. Amer. Geriat. Soc. 4, 429–437 (1956).

    PubMed  CAS  Google Scholar 

  71. Reifenstein, E. C., jr., and R. P. Howard: The Protein Anabolic Effectiveness in Postmenopausal and Senile Osteoporosis of a Single Injection of the Long-Acting Steroid Ester, Testosterone Enanthate. Metabolism 7, 365–373 (1958).

    Google Scholar 

  72. Junkmann, K.: Long-Acting Androgens. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 215, 85–92 (1952).

    Article  CAS  Google Scholar 

  73. Labhart, A., and B. Courvoisier: Osteoporosis in a Case of Eunuchism. Helv. med. Acta 17, 475–479 (1950).

    PubMed  CAS  Google Scholar 

  74. Nowakowski, H., and E. Gad Ermann: Regressive Vertebral Column Changes with Bilateral Testicular Atrophy and Anorchism. Verh. dtsch. Ges. inn. Med. 58, 400–405 (1952).

    Google Scholar 

  75. Nowakowski, H., and E. Gad Ermann: The Action of Sex Hormones on the Skeleton and Its Metabolism. The Metabolic Action of Steroid Hormones, pp.93–110. Berlin-Göttingen-Heidelberg: Springer- Verlag 1955.

    Google Scholar 

  76. Paschkis, K. E., A. E. Rakoff and A. Oantarow: Clinical Endocrinology, p. 552–553. New York: Paul B. Hoeber, Inc. 1954.

    Google Scholar 

  77. Varney, R. F., A. T. Kenyon and F. C. Koch: An Association of Short Stature, Retarded Sexual Development and High Urinary Gonadotropin Titers in Women. J. clin. Endoer. 2, 137–145 (1942).

    Article  CAS  Google Scholar 

  78. Albright, F., P. H. Smith and R. Fraser: A Syndrome Characterized by Primary Ovarian Insufficiency and Decreased Stature. Report of 11 Cases with a Digression on Hormonal Control of Axillary and Pubic Hair. Amer. J. med. Sei. 204, 625–648 (1942).

    Article  Google Scholar 

  79. Philipp, E.: Congenital Absence of the Genital Organs. Geburtsh. u. Frauenheilk. 11, 193 (1951).

    CAS  Google Scholar 

  80. Jores, A.: The Genital Organs and Their Diseases. In Handbuch der inneren Medizin. 4. Aufl., 7. Bd. Berlin-Göttingen-Heidelberg: Springer-Verlag 1955.

    Google Scholar 

  81. Castillo, E. B. del, F. A. De La Balze and J. Argonz: Syndrome of Rudimentary Ovaries with Estrogenic Insufficiency and Increase in Gonadotropins. J. clin. Endocr. 7, 385–422 (1947).

    Article  Google Scholar 

  82. Greenblatt, R. B., and H. E. Nieburgs: Turner’s Syndrome. J. clin. Endocr. 8, 993–1003 (1948).

    Article  PubMed  CAS  Google Scholar 

  83. Sohval, A. R., and L. J. Soffer: Congenital Testicular Deficiency. I. Absence of Spermatogonia, Sertoli and Leydig Cells as a cause of Eunuchoidism with Cryptorchidism. J. clin. Endocr. 12, 1229–1238 (1952).

    Article  PubMed  CAS  Google Scholar 

  84. Roth, K.: Combination Hormone Treatment of Dystrophia Adiposagenitalis with Hypothyroidism and Severe Osteoporosis. Ther. Gegenw. 91, 433 (1954).

    Google Scholar 

  85. Parson, W., K. R. Crispell and A. Ebbert, jr.: Abnormalities in N14 Excretion Rates after Ingestion of Tagged Glycine in Cushing’s Syndrome and Following ACTH Administration. J. clin. Invest. 31, 548–554 (1952).

    Article  PubMed  CAS  Google Scholar 

  86. Crispell, K. R., W. Parson and G. Harden: The Relation of Dietary Protein Consumption to N-15 Excretion in Normal Subjects and in Cushing’s Syndrome Utilizing N-15 Glycine Orally and Intravenously. J. clin. Invest. 33, 342–346 (1954).

    Article  PubMed  CAS  Google Scholar 

  87. Wilkins, L.: The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence, p. 229. Springfield, 111.: Charles C. Thomas, Publ. 1950.

    Google Scholar 

  88. Talbot, N. B., E. H. Sobel, J. W. Mcarthur and J.D. Crawford: Functional Endocrinology, From Birth Through Adolescence, p. 235. Cambridge, Mass.; Harvard University Press 1952.

    Google Scholar 

  89. Wells, B. B., and E. C. Kendall: The Influence of Corticosterone and C17 Hydroxyde- hydrocorticosterone (Compound E) on Somatic Growth. Proc. Staff Meet. Mayo Clin. 15, 324–328 (1940).

    Google Scholar 

  90. Becks, H., M. E. Simpson, C. H. Li and H. M. Evans: Effects of Adrenocorticotrophic Hormone (ACTH) on the Osseous System in Normal Rats. Endocrinology 34, 305–310 (1944).

    Article  CAS  Google Scholar 

  91. . W. Marx, C. H. Li and H. M. Evans: Antagonism of Pituitary Adrenocorticotrophic Hormone (ACTH) to the Action of Growth Hormone on the Osseous System of Hypophysectomized Rats. Endocrinology 34, 311–316 (1944).

    Article  Google Scholar 

  92. Albright, F. W. Parson and E. Bloomberg: Cushing’s Syndrome Interpreted as Hyperadrenocorticism leading to Hyperglueoneogenesis: Results of Treatment with Testosterone Propionate. J. clin. Endocr. 1, 375–384 (1941).

    Article  CAS  Google Scholar 

  93. Kepler, E. J., R. G. Sprague, H. L. Mason and M. H. Power: Aspects of Clinical Endocrinology: The Pathologic Physiology of Adrenal Cortical Tumors and Cushing’s Syndrome. Recent Progr. Hormone Res. 2, 345–389 (1948).

    CAS  Google Scholar 

  94. Sprague, R. G., H. L. Mason and M. H. Power: Chemistry, Physiology, and Clinical Endocrinology of the Adrenal Cortex: Physiologic Effects of Cortisone and ACTH in Man. Recent Progr. Hormone Res. 6, 315–372 (1951).

    Google Scholar 

  95. Irwin, J. W., P. H. Henneman, D. M. K. Wang and W. S. Burrage: Maintenance Cortisone in Intractable Asthma: Preliminary Observations of Undesirable Cortisone Effects. J. Allergy 25, 201–209 (1954).

    Article  PubMed  CAS  Google Scholar 

  96. Eisenhardt, L., and K.W. Thompson: Brief Consideration of the Present Status of So-Called Pituitary Basophilism, with Tabulation of Verified Cases. Yale J. Biol. Med. 11, 507–522 (1939).

    CAS  Google Scholar 

  97. Knowlton, A. I.: Cushing’s Syndrome. Bull. N. Y. Acad. Med. 29, 441–465 (1953).

    PubMed  CAS  Google Scholar 

  98. Sprague, R. G., M. H. Power, H. L. Mason, A. Albert, D. R. Mathieson, P. S. Hench, E. C. Kendall, C. H. Slocumb and H. F. Polley: Observations on the Physiologic Effects of Cortisone and ACTH in Man. A. M. A. Arch, intern. Med. 85, 199–258 (1950).

    Article  CAS  Google Scholar 

  99. Pearson, O. H., and L. P. Eliel: Hormone Therapy in Cancer. Experimental Studies with ACTH and Cortisone in Patients with Neoplastic Disease. Recent Progr. Hormone Res. 6, 373–416 (1951).

    Google Scholar 

  100. Eliel, L. P., L. Hellman, O.H. Pearson and B. Katz: The Effects of ACTH on the Electrolyte Content of Various Body Tissues. In Proceedings of the Second Clinical ACTH Conference, J. R. Mote, Editor. Vol. 1, pp. 196–212. New York: The Blakiston Company 1951.

    Google Scholar 

  101. Thorn, G. W., D. Jenkins, J. C. Laidlaw, F. C. Goetz, J. F. Dingman, W. L. Arons, D. H. P. Streeten and B.B.McCracken: Pharmacologic Aspects of Adrenocortical Steroids and ACTH in Man. New Engl. J. Med 248, 232–245, 284–294, 323–337 and 369–378,414–423, 588–601 (1953), and (Concluded): Clinical Uses of ACTH, Cortisone, and Hydrocortisone: Specific Replacement Therapy. New Engl. J. Med. 248, 632–646 (1953).

    Google Scholar 

  102. Teabeaut, R. F. L. Engel and H. Taylor: Hypokaliemic, Hypochloremic Alkalosis in Cushing’s Syndrome. Observations on the Effects of Treatment with Potassium Chloride and Testosterone. J. clin. Endocr. 10, 399–409 (1950).

    Article  PubMed  CAS  Google Scholar 

  103. Boland, E. W., and N. E. Headley: Management of Rheumatoid Arthritis with Smaller (Maintenance) Doses of Cortisone Acetate. J. Amer. med. Assoc. 144, 365–372 (1950).

    Article  CAS  Google Scholar 

  104. Steinbrocker, O., M. E. Ehrlich, M. Silver, W. Sicher, S. Berkowitz, S. Carp and H. Feinstein: The Clinical Application of Cortisone and ACTH in Arthritis and Related Conditions: Methods and Problems. Part. II: Side-Effects, Complications, Contraindications, Precautions, and Conclusions. Arizona Med. 8, 29–35 (1951).

    PubMed  CAS  Google Scholar 

  105. Soffer, L. J., and R. Bad er: Corticotropin and Cortisone in Acute Disseminated Lupus Erythematosus. Results of Long-Term Use. J. Amer. med. Assoc. 149,1002–1008 (1952).

    Article  CAS  Google Scholar 

  106. Soffer, L. J., S. K. Elster and D. J. Hamerman: Treatment of Acute Disseminated Lupus Erythematosus with Corticotropin and Cortisone. A. M. A. Arch, intern. Med. 93, 503–514 (1954).

    Article  CAS  Google Scholar 

  107. Kinsell, L. W.: ACTH and Cortisone - After Nearly Four Years of Intensive Clinical and Experimental Evaluation. J. clin. Endocr. 13, 120–122 (1953).

    Article  PubMed  CAS  Google Scholar 

  108. Berrios de La Luz, R., and R. Eulufi Marin: Rheumatoid Arthritis and Cushing’s Syndrome Consecutive to Prolonged Use of Cortisone; Clinical Case. Rev. Med. (Santiago) 81, 565–568 (1953).

    Google Scholar 

  109. Robinson, W. D., E. W. Boland, J. J. Btjnim, D. C. Crain, E. P. Engleman, W. Graham, L. M. Lockie, M. M. Montgomery, C. Ragan, M. W. Ropes, E. F. Rosenberg and C. J. Smyth: Rheumatism and Arthritis. Review of American and English Literature of Recent Years (Tenth Rheumatism Review). Ann. intern. Med. 39, 498- 618, 757–906 (1953).

    PubMed  CAS  Google Scholar 

  110. West, H. F., and G. R. Newns: Cortisone and Rheumatoid Disease. Lancet 1953, 1123–1126.

    Google Scholar 

  111. Engleman, E. P., M. A. Krupp, W. W. Saunders, L. E. Wilson and E. W. Fredell: Rheumatoid Arthritis: An Evaluation of Long-Term Treatment with Cortisone. Calif. Med. 80, 369–374 (1954).

    PubMed  CAS  Google Scholar 

  112. Bunim, J. J., M. Ziff and C. Mcewen: Evaluation of Prolonged Cortisone Therapy in Rheumatoid Arthritis: A Four Year Study. Amer. J. Med. 18, 27–40 (1955).

    Article  PubMed  CAS  Google Scholar 

  113. Burrage, W. S., A. C. Ritchie, H. C. Mansmann, jr., J. W. Irwin and A. B. Russ- field: The Use of Cortisone and Hydrocortisone in Allergy. Ann. intern. Med. 43, 1001–1018 (1955).

    PubMed  CAS  Google Scholar 

  114. Demartini, F., A. W. Grokoest and C. Ragan: Pathological Fractures in Patients with Rheumatoid Arthritis Treated with Cortisone. J. Amer. med. Assoc. 149, 750–752 (1952).

    Article  CAS  Google Scholar 

  115. Teicher, R., and C.T. Nelson: Osteoporosis and Pathological Fractures following Treatment with ACTH and Cortisone. J. invest. Dermat. 19, 205–210 (1952).

    CAS  Google Scholar 

  116. Teicher, R., and C.T. Nelson: Case Records of the Massachusetts General Hospital: Case 39221. New Engl. J. Med. 248, 945–950 (1953).

    Article  Google Scholar 

  117. Seze, S. de, A. Hubalt and J. C. Renier: Four Cases of Spontaneous Fractures Observed in Disorders Treated with Cortisone. Soc. Ophthal. Paris Meeting 4 • 18–53; through Presse med. 1953, 819.

    Google Scholar 

  118. Welch, R. G., and C. C. Forsyth: Still’s Disease Treated with A. C. T. H. and Cortisone. Gt. Ormond Str. J. (Lond.) 5, 1–6 (1953).

    Google Scholar 

  119. Luder, J.: Vertebral Collapse after Cortisone Therapy. Gt. Ormond Str. J. 7, 15–21 (1954).

    CAS  Google Scholar 

  120. Curtiss, P. H., jr., W. S. Clark and C. H. Herndon: Vertebral Fractures Resulting from Prolonged Cortisone and Corticotropin Therapy. J. Amer. med. Assoc. 156,467–469 (Oct. 2) 1954.

    Article  Google Scholar 

  121. Eisenstadt, W. S., and E.B. Cohen: Osteoporosis and Compression Fractures from Prolonged Cortisone and Corticotropin Therapy. Ann. Allergy 13, 252–256 (1955).

    PubMed  CAS  Google Scholar 

  122. Albright, F.,and P. H. Henneman: (Osteoporosis Produced by Cortisone-Like Steroids). Trans. Macy Conference on Metabolic Interrelations, with Special Reference to Calcium 5, 191–195 (1953).

    Google Scholar 

  123. Deakins, M. L., H. B. Friedgood and J. W. Ferrebee: Some Effects of Testosterone, Testosterone Propionate, Methyl Testosterone, Stilbestrol, and X-Ray Therapy in a Patient with Cushing’s Syndrome. J. clin. Endocr. 4, 376–384 (1944).

    Article  CAS  Google Scholar 

  124. Whitelaw, M. J.: A Case of Cushing’s Syndrome Treated with Testosterone Propionate. J. clin. Endocr. 4, 480–482 (1944).

    Article  CAS  Google Scholar 

  125. Hubble, D.: Cushing’s Syndrome and Thymic Carcinoma. Quart. J. Med. 18, 133–147 (1949).

    PubMed  CAS  Google Scholar 

  126. Kinsell, L. W., L. Boiling, J. W. Partridge and N. Foreman: Corticotropin (ACTH) and Cortisone; Newer Concepts of Their Use in Clinical Practice. Calif. Med. 78, 487–490 (1953).

    PubMed  CAS  Google Scholar 

  127. Bishop, P. M. F., R, R. De Mewbray, F. N. Gloyer and M. G. Thorne: The Treatment of Cushing’s Syndrome. Lancet 1954, 1137–1140.

    Google Scholar 

  128. Greenlee, R. G.: Hyperfunction of the Adrenal Cortex. Med. Clin. N. Amer. 39, 1081–1099 (1955).

    Google Scholar 

  129. Gill, A. M.: Treatment of Cushing’s Syndrome with Large Doses of Oestrin. Lancet 1937, 70.

    Google Scholar 

  130. Dunn, C. W.: Estrin in the Treatment of Cushing’s Syndrome. Lancet 1937, 344 and 828.

    Article  Google Scholar 

  131. Dunn, C. W.: The Cushing Syndrome. Endocrinology 22, 374–385 (1938).

    Article  Google Scholar 

  132. Rakoff, A. E. A. Cantarow and K. E. Paschkis: Cushing’s Syndrome (Two Cases Treated with Stilbestrol). J. clin. Endocr. 1, 912–915 (1941).

    Article  Google Scholar 

  133. Paschkis, K. E., P. A. Herbut, A. E. Rakoff and A. Cantarow: A Case of Cushing’s Syndrome with Adrenal Cortical Hyperplasia, Without Pituitary Basophilic Adenoma or Hyperplasia. J. clin. Endocr. 3, 212–217 (1943).

    Article  Google Scholar 

  134. Perloff, W. H., E. Rose and F. W. Sunderman: Therapeutic Observations in Cushing’s Syndrome: Effect of Various Agents on Calcium, Phosphorus, and Nitrogen Excretion in a Patient with Pituitary Basophilism. A. M. A. Arch, intern. Med. 72, 491–505 (1943).

    Article  Google Scholar 

  135. Kochakian, C. D.: The Protein Anabolic Effects of Steroid Hormones. In Vitamins and Hormones, R. S. Harris and K. V. Thimann, Editors. Vol. IV: 255–310. New York: Academic Press. Inc. 1946.

    Google Scholar 

  136. Vening, E. H., and J. S. L. Browne: Excretion of Glycogenic Corticoids and of 17- Ketosteroids in Various Endocrine and Other Disorders. J. clin. Endocr. 7, 79–101 (1947).

    Article  Google Scholar 

  137. Talbot, N. B., M. S. Wood, J. Worcester, E. Christo, A. M. Campbell and A. S. Zygmuntowicz: Further Observations on the Urinary Excretion of Water-Soluble Corticosteroids by Normal and Abnormal Subjects. J. clin. Endocr. 11, 1224–1236 (1951).

    Article  PubMed  CAS  Google Scholar 

  138. Talbot, N. B., A. S. Zygmuntowicz, M.Wood and E. Christo: Chapter 4: Observations on Adrenal Cortical “Sugar-Fat-Nitrogen” Hormone (“11–17-OCs”) and “17-Ketosteroid Precursor” Production by Normal and Abnormal Individuals of Various Ages with Comments on the Fact that (a) There May Be Two ACTH’s and (b) The Normal Adrenal Cortex May Not Produce True Androgens. In Proceedings of the First Clinical ACTH Conference, J. R. Mote, Editor, pp. 32–37, Philadelphia: Blakiston Company 1950.

    Google Scholar 

  139. Bliss, E. A., A. A. Sandberg, D. H. Nelson and K. Eik-Nes: The Normal Levels of 17-Hydroxycorticosteroids in the Peripheral Blood of Man. J. clin. Invest. 32. 818–823 (1953).

    Article  PubMed  CAS  Google Scholar 

  140. Samuels, L. T.: Effect of Aging on the Steroid Metabolism as Reflected in Plasma Levels. In Hormones and the Aging Process, E. T. Engle and G. Pincus, Editors, pp. 21–38. New York: Academic Press, Inc. 1956.

    Google Scholar 

  141. Sobel, H.: H. A. Zutrauen and J. Marmorston: The Collagen and Hexosamine Content of the Skin of Normal and Experimentally Treated Rats. Arch. Biochem. 46, 221–231 (1953).

    Article  PubMed  CAS  Google Scholar 

  142. Sobel, H. and J. Marmorston: The Effect of Cortisone on the Collagen and Hexosamine Content of the Skin and Femurs of One Year Old Rats. Endocrinology 55, 21–27 (1954).

    Article  PubMed  CAS  Google Scholar 

  143. Shorr, E., and A. C. Carter: Collagen and Hexosamine Content of Femurs of Rats. Proc. Soc. exp. Biol. (N. Y.) 87, 346–349 (1954).

    Google Scholar 

  144. Shorr, E., and A. C. Carter: The Possible Role of the Gel-Fiber Ratio of Connective Tissue in the Aging Process. J. Geront. 11, 2–7 (1956).

    Google Scholar 

  145. Talbot, N. B., and A. M. Butler: Urinary 17-Ketosteroid Assays in Clinical Medicine. J. clin. Endocr. 2, 724–729 (1942).

    Article  CAS  Google Scholar 

  146. Vinther-Paulsen, N.: Calcium and Phosphorus Intake in Senile Osteoporosis. Geriatrics 8, 76–79 (1953).

    PubMed  CAS  Google Scholar 

  147. Cooke, W. T., J. A. Barclay, A. D. T. Go van and L. Nagley: Osteoporosis Associated with Low Serum Phosphorus and Renal Glycosuria. A. M. A. Arch, intern. Med. 80, 147–164 (1947).

    Article  CAS  Google Scholar 

  148. Junkmann, K.: Long-Acting Estrogens. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 220, 358 (1953).

    Article  CAS  Google Scholar 

  149. Ufer, J.: Treatment of Climacteric Symptoms with Long-Acting Hormone Mixtures. Geburtsh. u. Frauenheilk. 14, 650 (1954).

    CAS  Google Scholar 

  150. Frank, E., J. Froewis, A. Rockenschaub and R. Ulm: Combined Treatment of Ovarian Insufficiency Phenomena with Estrogenic and Androgenic Steroid Hormones in a Depot Form. Zbl. Gynäk. 22, 859 (1954).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Division, The Squibb Institute for Medical Research, E.R. Squibb & Sons Division, Olin Mathieson Chemical Corporation, New York, USA

    E. C. Reifenstein Jr.

  2. Department of Medicine, New York Medical College, New York, N.Y., USA

    E. C. Reifenstein Jr.

Authors
  1. E. C. Reifenstein Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. II. Med. Univ.-klinik und Poliklinik, Hamburg-Eppendorf, Deutschland

    H. Nowakowski

Rights and permissions

Reprints and permissions

Copyright information

© 1958 Springer-Verlag oHG. Berlin · Göttingen · Heidelberg

About this chapter

Cite this chapter

Reifenstein, E.C. (1958). Steroid Hormones and the Aging Skeleton. In: Nowakowski, H. (eds) Hormone und Psyche die Endokrinologie des Alternden Menschen. Symposion der Deutschen Gesellschaft für Endokrinologie, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-87014-9_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-87014-9_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-02341-8

  • Online ISBN: 978-3-642-87014-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation